… 64 Cu-DOTATATE radiopharmaceutical may provide diagnostic and logistical benefits over
available imaging agents for patients with somatostatin receptor (… of 64 Cu-DOTATATE that …

… comparison of the in vitro and in vivo performance of 64 Cu-NODAGA-JR11 (NODAGA = 1,4,…
somatostatin receptor 2 antagonist, with the clinically used sst2 agonist 64 Cu-DOTA-TATE (…

Somatostatin receptor (SSTR) imaging has brought about impactful changes in clinical
management of neuroendocrine tumors (NETs), including pheochromocytoma and …

… This paper provides results from first-in-humans use of 64 Cu-DOTATATE, an avidly
binding somatostatin receptor ligand linked to a radioisotope with intermediate half-life and …

… , which is the primary somatostatin receptor subtype targeted by … being positive on somatostatin
receptor scintigraphy [23]. … observation that the 64 Cu-DOTA-TATE do not accumulate in …

… Our findings highlight the therapeutic potential of somatostatin analogs, especially of [ 177
Lu]Lu-DOTATATE, for the treatment of metastatic PHEO/PGLs. Repeated treatment cycles, …

… [ 64 Cu]Cu-DOTATATE and [ 68 Ga]Ga-DOTATATE for PET imaging of somatostatin receptor–…
effective doses for [ 55 Co]Co-DOTATATE were comparable to those for both [ 64 Cu]Cu-…

… However, a feature of most NENs is overexpression of somatostatin receptors (SSTRs).
The SSTR density on the tumor cell surface may reflect the degree of differentiation and …

… -approved [ 64 Cu]Cu-DOTA-TATE as a state-of-the art NET-PET/CT radiopharmaceutical. …
99m Tc, 68 Ga, and 64 Cu with higher affinity to somatostatin receptors and more favourable …

… 64 Cu-SARTATE can be safely administered to humans and will facilitate identification of
somatostatin receptor–… of SARTATE versus DOTATATE molecules for somatostatin receptor-2 …